Brief: India's Dr. Lal Pathlabs March-Quarter Consol Net Profit Falls
11/05/2023 09:31
May 11 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS :
* MARCH-QUARTER CONSOL NET PROFIT 567 MILLION RUPEES VERSUS
613
MILLION RUPEES
* MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 4.91 BILLION
RUPEES
VERSUS 4.86 BILLION RUPEES
Source text for Eikon: ID:
Further company coverage: DLPA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise